Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors are game-changers in the treatment of T2DM and are currently promoted by major clinical guidelines among potential first-line pharmacological options after failure/intolerance to metformin, especially in individuals with an atherosclerotic cardiovascular disease phenotype (GLP-1 RAs) [174]
Managing Insulin Resistance with Tirzepatide Injections Insulin resistance is a common feature of type 2 diabetes, where the body becomes less sensitive to the effects of insulin
Our data suggest that reduced GSH synthesis rates and possibly increased irreversible utilization of glutathione contribute to its low concentration in type 2 diabetes
Hyaluronic Acid helps hydrate and assists with circulation whilst fighting free radicals and maintaining skin elasticity
So, Todd stayed on the drug
GHK-Cu (skin, hair, inflammation) Article: GHK-Cu studied for skin, hair and healing GHK-Cu is a naturally occurring copper-binding peptide discovered in human plasma that activates thousands of genes involved in healing, reducing inflammation, and protecting against oxidative stress
